홈 › 만성 폐쇄성 폐질환 › 오하이오
오하이오의 만성 폐쇄성 폐질환 임상 시험
만성 폐쇄성 폐질환 관련 연구 16개가 오하이오 내 여러 지역에서 참여자를 모집하고 있습니다.
오하이오의 도시
공식 연구 텍스트(영어)
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50003, Columbus
피험자 모집 중2상
40세 ~ 80세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07725939Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Dayton Clinical Research- Site Number : 8400124, Dayton
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07190209Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Asthma & Allergy Center - Toledo- Site Number : 8400110, Toledo
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07190222A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Cleveland
- Research Site, Marion
피험자 모집 중2상
40세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Columbus
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Toledo Institute of Clinical Research Inc., Toledo
피험자 모집 중2/3상
35세 ~ 80세 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Blue Ash
- Research Site, Columbus
- Research Site, Marion
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT06283966A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 104, Cleveland
피험자 모집 중3상
18세 ~ 80세 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT07555483To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Remington-Davis Research, Columbus
피험자 모집 중2상
40세 ~ 85세 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT07684820Multi-Center Clean Air Randomized Controlled Trial in COPD
- Cleveland Clinic, Cleveland
피험자 모집 중3상
40세 이상 · 모든 성별 · 2026. 7. 31. 업데이트됨 · NCT06376994PEP Buddy in Pulmonary Rehabilitation
- Cincinnati VA Medical Center, Cincinnati, OH, Cincinnati
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
피험자 모집 중
40세 ~ 89세 · 모든 성별 · 2026. 7. 24. 업데이트됨 · NCT07404826Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Ohio State University Medical Center - Ohio State Lung Center, Columbus
피험자 모집 중
40세 ~ 80세 · 모든 성별 · 2026. 4. 28. 업데이트됨 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Cleveland Clinic Foundation, Cleveland
- The Ohio State University, Columbus
피험자 모집 중
40세 ~ 84세 · 모든 성별 · 2026. 4. 24. 업데이트됨 · NCT06891755Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD
- Cleveland Clinic Foundation, Cleveland
피험자 모집 중
40세 이상 · 모든 성별 · 2025. 10. 30. 업데이트됨 · NCT07059637myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- Cincinnati VA Medical Center, Cincinnati
- Cleveland Clinic Foundation, Cleveland
- Ohio State University Wexner Medical Center, Columbus
피험자 모집 중
30세 이상 · 모든 성별 · 2025. 2. 6. 업데이트됨 · NCT05204888PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
- MetroHealth, Cleveland
피험자 모집 중
18세 이상 · 모든 성별 · 2023. 10. 12. 업데이트됨 · NCT05306743ClinicalTrials.gov 출처, 2026. 9. 29. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.